Sign inJoin waitlistJoin the waitlist

JK

Julie Kanter

Professor and Award of Tenure · University of Alabama Hospital

Credentials: · · · · · ·

History

University of Alabama Hospital
Present

Pediatric Hematology-Oncology
2006–2007
Pediatrics
2003–2006
Tulane University School of Medicine
1999–2003

Research

Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
New England Journal of Medicine · 2017 · 702 citations
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
New England Journal of Medicine · 2019 · 481 citations
A Phase 3 Trial of l-Glutamine in Sickle Cell Disease
New England Journal of Medicine · 2018 · 451 citations

AP
Alyssa PhD
20 papers
Sophie Lanzkron
18 papers
Deepa Manwani
16 papers
Allison King
15 papers
Jane Hankins
15 papers
Nirmish Shah
15 papers
Victor Gordeuk
14 papers
Robert Adams
13 papers
Jeffrey Glassberg
11 papers
Lewis Hsu
11 papers
Mark Walters
11 papers
Payal Desai
11 papers

Grants

Hypoxemia with Sleep in Sickle Cell Anemia-Prevalence, Clinical and Cellular Impact & Response to Therapy: A Multi-Site Prospective Study Accessing New Collaborative Pathways
National Heart, Lung, and Blood Institute · R01
PI · $1.4M · Univ of North Carolina Chapel Hill
2025–2029
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $7.6M · University of Alabama at Birmingham
2022–2027
DISPLACE: Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
National Heart, Lung, and Blood Institute · R01
Contact PI · $5M · University of Alabama at Birmingham
2017–2023
Implementation of a Sickle Cell Enhanced Novel Care Network in South Carolina (iSCENSC)
National Heart, Lung, and Blood Institute · U01
PI · $2.1M · Medical University of South Carolina
2016–2022

Clinical trials

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Principal investigator · Recruiting
RTI International
2023–2027
Dissemination and Implementation of Stroke Prevention Looking at the Care Environment
Principal investigator · Completed
University of Alabama at Birmingham
2020–2023
Evaluating Barriers to Stroke Screening and Prevention in Children With Sickle Cell Disease
Principal investigator · Completed
Medical University of South Carolina
2018–2019
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Site PI · Recruiting · Phase 1, Phase 2
Novartis Pharmaceuticals
2024–2030